Chromatin remodeling system p300-HDAC2-Sin3A is involved in Arginine Starvation-Induced HIF-1α Degradation at the ASS1 promoter for ASS1 Derepression

被引:21
作者
Tsai, Wen-Bin [1 ]
Long, Yan [1 ]
Chang, Jeffrey T. [2 ]
Savaraj, Niramol [3 ]
Feun, Lynn G. [3 ]
Jung, Manfred [4 ]
Chen, Helen H. W. [5 ]
Kuo, Macus Tien [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA
[3] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA
[4] Albert Ludwigs Univ Freiburg, Inst Pharmaceut Sci, Freiburg, Germany
[5] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Radiat Oncol, Tainan, Taiwan
关键词
PROTEIN LYSINE ACETYLATION; ARGININOSUCCINATE SYNTHETASE; TRANSLATION INITIATION; DEIMINASE RESISTANCE; HIF-BINDING; EXPRESSION; MECHANISM; ENHANCERS; SIN3;
D O I
10.1038/s41598-017-11445-0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Argininosuccinate synthetase 1 (ASS1) is the key enzyme that controls biosynthesis of arginine (Arg). ASS1 is silenced in many human malignancies therefore, these tumors require extracellular Arg for growth. The Arg-degrading recombinant protein, pegylated arginine deiminase (ADI-PEG20), has been in clinical trials for targeting Arg auxotrophic tumors by Arg starvation therapy. Resistance to Arg starvation is often developed through reactivation of ASS1 expression. We previously demonstrated that ASS1 silencing is controlled by HIF-1 alpha and Arg starvation-reactivated ASS1 is associated with HIF-1 alpha downregulation. However, mechanisms underlying ASS1 repression and HIF-1 alpha turnover are not known. Here, we demonstrate that interplay of p300-HDAC2-Sin3A in the chromatin remodeling system is involved in HIF-1 alpha degradation at the ASS1 promoter. The histone acetyltransferase p300 is normally associated with the ASS1 promoter to maintain acetylated H3K14ac and H3K27ac for ASS1 silencing. Arg starvation induces p300 dissociation, allowing histone HDAC2 and cofactor Sin3A to deacetylate these histones at the ASS1 promoter, thereby facilitating HIF-1 alpha-proteasomal complex, driven by PHD2, to degrade HIF-1 alpha in situ. Arg starvation induces PHD2 and HDAC2 interaction which is sensitive to antioxidants. This is the first report describing epigenetic regulation of chromosomal HIF-1 alpha turnover in gene activation that bears important implication in cancer therapy.
引用
收藏
页数:12
相关论文
共 42 条
[1]   Regulation of chromatin by histone modifications [J].
Bannister, Andrew J. ;
Kouzarides, Tony .
CELL RESEARCH, 2011, 21 (03) :381-395
[2]   Emerging Roles of Epigenetic Regulator Sin3 in Cancer [J].
Bansal, N. ;
David, G. ;
Farias, E. ;
Waxman, S. .
ADVANCES IN CANCER RESEARCH, VOL 130, 2016, 130 :113-135
[3]   Genome-wide Map of Nuclear Protein Degradation Shows NCoR1 Turnover as a Key to Mitochondrial Gene Regulation [J].
Catic, Andre ;
Suh, Carol Y. ;
Hill, Cedric T. ;
Daheron, Laurence ;
Henkel, Theresa ;
Orford, Keith W. ;
Dombkowski, David M. ;
Liu, Tao ;
Liu, X. Shirley ;
Scadden, David T. .
CELL, 2013, 155 (06) :1380-1395
[4]   Histone H3K27ac separates active from poised enhancers and predicts developmental state [J].
Creyghton, Menno P. ;
Cheng, Albert W. ;
Welstead, G. Grant ;
Kooistra, Tristan ;
Carey, Bryce W. ;
Steine, Eveline J. ;
Hanna, Jacob ;
Lodato, Michael A. ;
Frampton, Garrett M. ;
Sharp, Phillip A. ;
Boyer, Laurie A. ;
Young, Richard A. ;
Jaenisch, Rudolf .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (50) :21931-21936
[5]   Protein Lysine Acetylation by p300/CBP [J].
Dancy, Beverley M. ;
Cole, Philip A. .
CHEMICAL REVIEWS, 2015, 115 (06) :2419-2452
[6]   Structural and Functional Characterization of the α-Tubulin Acetyltransferase MEC-17 [J].
Davenport, Andrew M. ;
Collins, Leslie N. ;
Chiu, Hui ;
Minor, Paul J. ;
Sternberg, Paul W. ;
Hoelz, Andre .
JOURNAL OF MOLECULAR BIOLOGY, 2014, 426 (14) :2605-2616
[7]   KATs in cancer: functions and therapies [J].
Farria, A. ;
Li, W. ;
Dent, S. Y. R. .
ONCOGENE, 2015, 34 (38) :4901-4913
[8]   Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase [J].
Feun, L. G. ;
Marini, A. ;
Walker, G. ;
Elgart, G. ;
Moffat, F. ;
Rodgers, S. E. ;
Wu, C. J. ;
You, M. ;
Wangpaichitr, M. ;
Kuo, M. T. ;
Sisson, W. ;
Jungbluth, A. A. ;
Bomalaski, J. ;
Savaraj, N. .
BRITISH JOURNAL OF CANCER, 2012, 106 (09) :1481-1485
[9]   Arginine deprivation in cancer therapy [J].
Feun, Lynn G. ;
Kuo, Macus Tien ;
Savaraj, Niramol .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2015, 18 (01) :78-82
[10]   Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors [J].
Finnin M.S. ;
Donigian J.R. ;
Cohen A. ;
Richon V.M. ;
Rifkind R.A. ;
Marks P.A. ;
Breslow R. ;
Pavletich N.P. .
Nature, 1999, 401 (6749) :188-193